These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 3489072

  • 1. Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
    Mayer RA, Kindt MV, Heikkila RE.
    J Neurochem; 1986 Oct; 47(4):1073-9. PubMed ID: 3489072
    [Abstract] [Full Text] [Related]

  • 2. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 3. Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
    Ofori S, Heikkila RE, Nicklas WJ.
    J Pharmacol Exp Ther; 1989 Oct 08; 251(1):258-66. PubMed ID: 2571719
    [Abstract] [Full Text] [Related]

  • 4. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
    Sershen H, Mason MF, Debler EA, Lajtha A.
    Eur J Pharmacol; 1986 Jul 31; 126(3):337-9. PubMed ID: 3489627
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC.
    Neurosci Lett; 1985 Dec 18; 62(3):389-94. PubMed ID: 3912685
    [Abstract] [Full Text] [Related]

  • 6. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and related compounds on the uptake of [3H]3,4-dihydroxyphenylethylamine and [3H]5-hydroxytryptamine in neostriatal synaptosomal preparations.
    Heikkila RE, Youngster SK, Manzino L, Cabbat FS, Duvoisin RC.
    J Neurochem; 1985 Jan 18; 44(1):310-3. PubMed ID: 3871120
    [Abstract] [Full Text] [Related]

  • 7. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Perry TL, Yong VW, Jones K, Wall RA, Clavier RM, Foulks JG, Wright JM.
    Neurosci Lett; 1985 Aug 05; 58(3):321-6. PubMed ID: 3876525
    [Abstract] [Full Text] [Related]

  • 8. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
    Shen RS, Abell CW, Gessner W, Brossi A.
    FEBS Lett; 1985 Sep 23; 189(2):225-30. PubMed ID: 3876242
    [Abstract] [Full Text] [Related]

  • 9. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
    Irwin I, Langston JW, DeLanney LE.
    Life Sci; 1987 Feb 23; 40(8):731-40. PubMed ID: 3492652
    [Abstract] [Full Text] [Related]

  • 10. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ, Costall B, Domeney AM, Jenner P, Kelly ME, Marsden CD, Naylor RJ.
    Nature; 1987 Feb 23; 319(6048):56-7. PubMed ID: 3484542
    [Abstract] [Full Text] [Related]

  • 11. Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.
    Ricaurte GA, Langston JW, DeLanney LE, Irwin I, Brooks JD.
    Neurosci Lett; 1985 Sep 06; 59(3):259-64. PubMed ID: 3932903
    [Abstract] [Full Text] [Related]

  • 12. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
    Schinelli S, Zuddas A, Kopin IJ, Barker JL, di Porzio U.
    J Neurochem; 1988 Jun 06; 50(6):1900-7. PubMed ID: 3259619
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes.
    Willoughby J, Cowburn RF, Hardy JA, Glover V, Sandler M.
    J Neurochem; 1989 Feb 06; 52(2):627-31. PubMed ID: 2783454
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
    Chang GD, Ramirez VD.
    Brain Res; 1986 Mar 12; 368(1):134-40. PubMed ID: 3485463
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Bradbury AJ, Costall B, Domeney AM, Testa B, Jenner PG, Marsden CD, Naylor RJ.
    Neurosci Lett; 1985 Oct 24; 61(1-2):121-6. PubMed ID: 2417166
    [Abstract] [Full Text] [Related]

  • 19. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
    Sayre LM, Arora PK, Iacofano LA, Harik SI.
    Eur J Pharmacol; 1986 May 13; 124(1-2):171-4. PubMed ID: 3487462
    [Abstract] [Full Text] [Related]

  • 20. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
    Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ, Cadet JL.
    J Neurosci; 1992 May 13; 12(5):1658-67. PubMed ID: 1578260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.